| Dementia prevention, intervention, and care G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ... The Lancet 390 (10113), 2673-2734, 2017 | 2571 | 2017 |
| Assessment and management of behavioral and psychological symptoms of dementia HC Kales, LN Gitlin, CG Lyketsos Bmj 350, 2015 | 603 | 2015 |
| Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm DT Maust, HM Kim, LS Seyfried, C Chiang, J Kavanagh, LS Schneider, ... JAMA psychiatry 72 (5), 438-445, 2015 | 408 | 2015 |
| Nonpharmacologic management of behavioral symptoms in dementia LN Gitlin, HC Kales, CG Lyketsos Jama 308 (19), 2020-2029, 2012 | 312 | 2012 |
| Risk of mortality among individual antipsychotics in patients with dementia HC Kales, HM Kim, K Zivin, M Valenstein, LS Seyfried, C Chiang, ... American Journal of Psychiatry 169 (1), 71-79, 2012 | 312 | 2012 |
| Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications HC Kales, M Valenstein, HM Kim, JF McCarthy, D Ganoczy, ... American Journal of Psychiatry 164 (10), 1568-1576, 2007 | 292 | 2007 |
| Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel HC Kales, LN Gitlin, CG Lyketsos, ... Journal of the American Geriatrics Society 62 (4), 762-769, 2014 | 269 | 2014 |
| Benzodiazepine use among depressed patients treated in mental health settings M Valenstein, KK Taylor, K Austin, HC Kales, JF McCarthy, FC Blow American Journal of Psychiatry 161 (4), 654-661, 2004 | 180 | 2004 |
| Trends in antipsychotic use in dementia 1999-2007 HC Kales, K Zivin, HM Kim, M Valenstein, C Chiang, RV Ignacio, ... Archives of general psychiatry 68 (2), 190-197, 2011 | 176 | 2011 |
| Cerebrovascular disease and late-life depression HC Kales, DF Maixner, AM Mellow The American Journal of Geriatric Psychiatry 13 (2), 88-98, 2005 | 174 | 2005 |
| Dementia prevention, intervention, and care: 2020 report of the Lancet Commission G Livingston, J Huntley, A Sommerlad, D Ames, C Ballard, S Banerjee, ... The Lancet 396 (10248), 413-446, 2020 | 153 | 2020 |
| Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia. Management of neuropsychiatric symptoms of dementia in clinical settings … HC Kales, LN Gitlin, CG Lyketsos J Am Geriatr Soc 62 (4), 762-769, 2014 | 113 | 2014 |
| Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression HC Kales, P Chen, FC Blow, DE Welsh, AM Mellow The American Journal of Geriatric Psychiatry 13 (6), 441-449, 2005 | 113 | 2005 |
| Association of antipsychotic use with mortality risk in patients with Parkinson disease D Weintraub, C Chiang, HM Kim, J Wilkinson, C Marras, B Stanislawski, ... JAMA neurology 73 (5), 535-541, 2016 | 109 | 2016 |
| Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg K Zivin, PN Pfeiffer, ASB Bohnert, D Ganoczy, FC Blow, BK Nallamothu, ... American Journal of Psychiatry 170 (6), 642-650, 2013 | 108 | 2013 |
| Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis D Weintraub, P Chen, RV Ignacio, E Mamikonyan, HC Kales Archives of neurology 68 (7), 899-904, 2011 | 106 | 2011 |
| Adherence to depression treatment in older adults K Zivin, HC Kales Drugs & aging 25 (7), 559-571, 2008 | 105 | 2008 |
| Predictors of suicide in patients with dementia LS Seyfried, HC Kales, RV Ignacio, Y Conwell, M Valenstein Alzheimer's & dementia 7 (6), 567-573, 2011 | 102 | 2011 |
| Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. HC Kales, JR Dequardo, R Tandon Progress in neuro-psychopharmacology & biological psychiatry, 1999 | 100 | 1999 |
| Health care utilization by older patients with coexisting dementia and depression HC Kales, FC Blow, LA Copeland, RC Bingham, EE Kammerer, ... American Journal of Psychiatry 156 (4), 550-556, 1999 | 85 | 1999 |
